Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
polyethylene glycol + prucalopride
- Development stage
- Phase 4
- Lead developer
- Queen's University
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Oral
01
Overview
polyethylene glycol-Queen's University-bowel preparation refers to a specific bowel cleansing regimen evaluated by Queen's University in a Phase 3 clinical trial (NCT01844466). This regimen consists of a split-dose administration of polyethylene glycol (PEG), an osmotic laxative, in combination with prucalopride, a selective 5-HT4 receptor agonist. PEG functions by creating an osmotic gradient that retains water within the intestinal lumen, thereby increasing stool volume and stimulating bowel movements. Prucalopride acts as a prokinetic agent, enhancing colonic motility to facilitate the transit of a colon capsule through the gastrointestinal tract. This combination is specifically designed to optimize mucosal visualization and capsule completion rates in patients undergoing colon capsule endoscopy, addressing the limitations of standard PEG-only preparations.
- Other names
- PEG + prucalopridePEG and prucalopride
02
Targets
HTR4 (5-Hydroxytryptamine receptor 4)
Beyond the preview
Go deeper on polyethylene glycol + prucalopride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on polyethylene glycol + prucalopride.